SHSE:600671 (China)
Â
Class A
Â¥
8.86
(+2.31%)
Dec 26
Business Description
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd
NAICS : 325412
SIC : 2834
ISIN : CNE000000BF3
Share Class Description:
SHSE:600671: Class ACompare
Compare
Traded in other countries / regions
600671.China IPO Date
1993-08-23Description
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd is engaged in producing proprietary Chinese medicines, biopharmaceuticals, healthy foods, medical equipment, and other medicines in China.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.27 | |||||
| Equity-to-Asset | 0.09 | |||||
| Debt-to-Equity | 3.35 | |||||
| Debt-to-EBITDA | -24.34 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 1.2 | |||||
| Beneish M-Score | -1.61 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -15.9 | |||||
| 3-Year EBITDA Growth Rate | 25.9 | |||||
| 3-Year EPS without NRI Growth Rate | 8.7 | |||||
| 3-Year FCF Growth Rate | -13.5 | |||||
| 3-Year Book Growth Rate | -20.1 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 22.12 | |||||
| 9-Day RSI | 31.99 | |||||
| 14-Day RSI | 38.75 | |||||
| 6-1 Month Momentum % | 18.29 | |||||
| 12-1 Month Momentum % | -21.83 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.65 | |||||
| Quick Ratio | 0.45 | |||||
| Cash Ratio | 0.13 | |||||
| Days Inventory | 167.77 | |||||
| Days Sales Outstanding | 91.8 | |||||
| Days Payable | 227.22 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | 1.52 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 37.56 | |||||
| Operating Margin % | -3.85 | |||||
| Net Margin % | -9.05 | |||||
| FCF Margin % | -29.62 | |||||
| ROE % | -97.34 | |||||
| ROA % | -4.27 | |||||
| ROIC % | -2.87 | |||||
| ROC (Joel Greenblatt) % | -2.89 | |||||
| ROCE % | -4.34 | |||||
| Years of Profitability over Past 10-Year | 4 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 6.47 | |||||
| PB Ratio | 30.93 | |||||
| Price-to-Tangible-Book | 41.24 | |||||
| EV-to-EBIT | -258.1 | |||||
| EV-to-EBITDA | -258.1 | |||||
| EV-to-Revenue | 7.41 | |||||
| EV-to-FCF | -24.8 | |||||
| Price-to-Median-PS-Value | 0.78 | |||||
| Earnings Yield (Greenblatt) % | -0.39 | |||||
| FCF Yield % | -4.51 | |||||
| Forward Rate of Return (Yacktman) % | 2.61 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 160.351 | ||
| EPS (TTM) (Â¥) | -0.119 | ||
| Beta | 0.01 | ||
| Volatility % | 51.17 | ||
| 14-Day RSI | 38.75 | ||
| 14-Day ATR (Â¥) | 0.377041 | ||
| 20-Day SMA (Â¥) | 9.271 | ||
| 12-1 Month Momentum % | -21.83 | ||
| 52-Week Range (Â¥) | 5.85 - 12.41 | ||
| Shares Outstanding (Mil) | 121.78 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Frequently Asked Questions
What is Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd(SHSE:600671)'s stock price today?
The current price of SHSE:600671 is ¥8.86. The 52 week high of SHSE:600671 is ¥12.41 and 52 week low is ¥5.85.
When is next earnings date of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd(SHSE:600671)?
The next earnings date of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd(SHSE:600671) is .
Does Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd(SHSE:600671) pay dividends? If so, how much?
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd(SHSE:600671) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers